You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 140 No. 11, November 2004 TABLE OF CONTENTS
  Archives
  •  Online Features
  Off-Center Fold
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Diagnosis
 •Dermatologic Disorders, Other
 •Drug Therapy
 •Adverse Effects
 •Alert me on articles by topic

Pustular Plaques on the Face of a Patient With Renal Failure—Diagnosis

Arch Dermatol. 2004;140:1393-1398.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Diagnosis: Iododerma.

MICROSCOPIC FINDINGS AND CLINICAL COURSE

A skin biopsy specimen obtained from an early pustular lesion showed focal subepidermal and intraepidermal vesicle formation, a dense neutrophilic infiltrate involving the entire dermis and extending into the subcutaneous tissue, and prominent leukocytoclasis and fibrinoid changes in the walls of small blood vessels. Direct immunofluorescence studies showed strong staining with IgG and IgA in the superficial and middermal vessels and with fibrinogen in the superficial dermal vessels. Special staining of the tissue sections did not demonstrate any bacterial or fungal organisms.

The patient was initially empirically treated with antibacterial agents and acyclovir. Methylprednisolone sodium succinate (Solu-Medrol, 60 mg/d) was added to her regimen 1 day later because she had developed mild hoarseness and her skin lesions had not improved. On hospital day 3, she was started on a 3-day course of pulse methylprednisolone (1 g/d) for the development of new hemorrhagic bullae on her extremities. Dapsone (100 mg/d) was . . . [Full Text of this Article]

DISCUSSION







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.